30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Anna Berkenblit

Track

Insider profile

Currently holds a position at ImmunoGen Inc

Positions

Position Company Period
Senior Vice President and Chief Medical Officer ImmunoGen Inc Feb. 1, 2019 -
Vice President and Chief Medical Officer ImmunoGen Inc April 1, 2015 - Feb. 1, 2019
Anna Berkenblit's trades of ImmunoGen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-02 2023-11-02
US ImmunoGen Inc (IMGN)
PrS Proposed sale
54,030
55.95
US$3,677,466 		54,030 55.95 US$3,677,466
2023-09-19 2023-09-19
US ImmunoGen Inc (IMGN)
PrS Proposed sale
85,587
161.65
US$3,634,545 		85,587 161.65 US$3,634,545
2023-09-18 2023-09-18
US ImmunoGen Inc (IMGN)
PrS Proposed sale
28,699
195.42
US$1,659,135 		28,699 195.42 US$1,659,135
2023-09-13 2023-09-13
US ImmunoGen Inc (IMGN)
PrS Proposed sale
100,000
16.09
US$1,609,337 		100,000 16.09 US$1,609,337
2023-09-11 2023-09-11
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.77
US$788,583 		50,000 15.77 US$788,583
2023-09-06 2023-09-06
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.67
US$783,739 		50,000 15.67 US$783,739
2023-09-01 2023-09-01
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
16.01
US$800,444 		50,000 16.01 US$800,444
2023-08-31 2023-08-31
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.76
US$788,011 		50,000 15.76 US$788,011
2023-08-30 2023-08-30
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.90
US$795,024 		50,000 15.90 US$795,024
2023-08-29 2023-08-29
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.95
US$797,613 		50,000 15.95 US$797,613
2023-08-28 2023-08-28
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.33
US$766,652 		50,000 15.33 US$766,652
2023-08-25 2023-08-25
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.97
US$798,359 		50,000 15.97 US$798,359
2023-08-24 2023-08-24
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
16.02
US$800,996 		50,000 16.02 US$800,996
2023-08-23 2023-08-23
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
16.50
US$825,025 		50,000 16.50 US$825,025
2023-08-22 2023-08-22
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
16.37
US$818,475 		50,000 16.37 US$818,475
2023-08-21 2023-08-21
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.75
US$787,642 		50,000 15.75 US$787,642
2023-08-18 2023-08-18
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.75
US$787,642 		50,000 15.75 US$787,642
2023-08-17 2023-08-17
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.81
US$790,348 		50,000 15.81 US$790,348
2023-08-16 2023-08-16
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.83
US$791,552 		50,000 15.83 US$791,552
2023-08-15 2023-08-15
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
15.54
US$777,117 		50,000 15.54 US$777,117
2023-08-14 2023-08-14
US ImmunoGen Inc (IMGN)
PrS Proposed sale
50,000
14.92
US$746,147 		50,000 14.92 US$746,147
2020-02-25 2020-02-24
US ImmunoGen Inc (IMGN)
PlS Planned sale
25,803 -20.8%
4.99
US$128,757 		25,803 -20.8% 4.99 US$128,757
2019-02-25 2018-02-22
US ImmunoGen Inc (IMGN)
PlS Planned sale
16,562 -12.2%
5.60
US$92,747 		16,562 -12.2% 5.60 US$92,747
2018-02-23 2018-02-21
US ImmunoGen Inc (IMGN)
PlS Planned sale
17,329 -10.7%
10.88
US$188,540 		17,329 -10.7% 10.88 US$188,540